Assembly Biosciences, Inc. (ASMB)
NASDAQ·Healthcare·Biotechnology
$26.97
-2.02%
Mkt Cap $442.09M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | $7.42M | $42.46M | +472.24% | -$0.51 | $2.48 | +586.27% | — | — |
| Q4 2025 Nov 10, 2025 | $7.46M | $10.79M | +44.64% | -$0.50 | -$0.72 | -44.00% | — | — |
| Q3 2025 Aug 6, 2025 | $9.32M | $9.63M | +3.24% | -$0.65 | -$1.33 | -103.57% | — | — |
| Q2 2025 May 8, 2025 | $7.41M | $9.42M | +27.03% | -$2.01 | -$1.17 | +41.79% | — | — |
| Q1 2025 Mar 20, 2025 | $3.55M | $7.36M | +107.24% | -$1.75 | -$1.57 | +10.29% | — | — |
| Q4 2024 Nov 7, 2024 | $7.05M | $6.84M | -2.91% | -$2.02 | -$1.51 | +25.25% | — | — |
| Q3 2024 Aug 8, 2024 | $5.96M | $8.53M | +43.17% | -$2.96 | -$1.98 | +33.11% | — | — |
| Q2 2024 May 8, 2024 | — | $5.79M | — | -$2.74 | -$1.66 | +39.42% | — | — |
| Q1 2024 Mar 27, 2024 | — | $7.16M | — | -$2.88 | -$2.15 | +25.35% | — | — |
| Q4 2023 Nov 8, 2023 | — | — | — | -$2.76 | -$3.24 | -17.39% | — | — |
| Q3 2023 Aug 9, 2023 | — | — | — | -$3.48 | -$3.84 | -10.34% | — | — |
| Q2 2023 May 4, 2023 | — | — | — | -$4.44 | -$4.44 | +0.00% | — | — |
| Q1 2023 Mar 22, 2023 | — | — | — | -$6.72 | -$5.52 | +17.86% | — | — |
| Q4 2022 Nov 8, 2022 | — | — | — | -$5.64 | -$5.76 | -2.13% | — | — |
| Q3 2022 Aug 9, 2022 | — | — | — | -$5.88 | -$6.12 | -4.08% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$5.88 | -$5.76 | +2.04% | — | — |
| Q1 2022 Mar 10, 2022 | $1.56M | — | — | -$6.00 | -$4.92 | +18.00% | — | — |
| Q4 2021 Nov 4, 2021 | $7.85M | $6.25M | -20.29% | -$6.60 | -$4.92 | +25.45% | — | — |
| Q3 2021 Aug 5, 2021 | — | — | — | -$7.68 | -$6.60 | +14.06% | — | — |
| Q2 2021 May 6, 2021 | — | — | — | -$9.48 | -$8.28 | +12.66% | — | — |